Central African Journal of Public Health

| Peer-Reviewed |

Difference in Adherence to Anti-Retroviral Therapy in Resource - Constrained Setting: Adolescents and Young Adults in Rural and Urban Residents in Nigeria

Received: 05 October 2018    Accepted: 18 October 2018    Published: 13 November 2018
Views:       Downloads:

Share This Article

Abstract

Adherence to antiretroviral medicines is essential to halt human immunodeficiency virus progression, increase CD4 counts, decrease virologic impact, and improve quality of life for the infected people. However, sustaining good adherence among adolescents and young adults has been a challenge caused by various problems such as distance to clinic, improved CD4 count which lead to complacency in adherence, and the nature of the environment. Compare to the general population, there is low adherence to anti-retroviral therapy among adolescents and young adults. The study aims to assess the difference in adherence to anti-retroviral therapy between adolescents and young adults in rural and urban areas in resource-constrained settings. This was a retrospective cross-sectional study carried out between January 2011 – December 2014 with a sample size of 287 patients who accessed care for HIV in Federal Medical Center Makurdi, located in the Middle-Belt region of Nigeria. Univariate analysis was conducted using descriptive statistics. Pharmacy refill was used to measure adherence level while the data was analyzed using independent t-test and Chi-Square test. A p value < 0.05 was considered to be statistically significant in the study. In line with literature review, adherence level of at least 95% was considered optimal while anything less than that was deemed suboptimal. Adherence for patients in urban settings was 90.36% (182) while it was 95.12% (105) for those in rural settings (p = 0.001, 95% CI (-8.069, -1.450)). Among patients in rural settings, 57.14% (60) had adherence level of 100% compare to only 42.3% (77) from urban settings (p = 0.080, 95% CI (.052,.116)). Patients in rural settings in Federal Medical Center Makurdi in Benue State are more likely to have a comparative better health output than their counterparts in urban settings going by their adherence levels.

DOI 10.11648/j.cajph.20180406.11
Published in Central African Journal of Public Health (Volume 4, Issue 6, December 2018)
Page(s) 168-174
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Adherence, HIV, Young Adults, Adolescents, Urban and Rural

References
[1] Volberding P. The impact of HIV research on health outcome and healthcare policy. Ann Oncol. 2011; 22 (SUPPL. 7):50–3.
[2] Tougas ME, Hayden JA, McGrath PJ, Huguet A, Rozario S. A systematic review exploring the social cognitive theory of self-regulation as a framework for chronic health condition interventions. PLoS One. 2015; 10 (8):1–19.
[3] Groh K, Audet CM, Baptista A, Sidat M, Vergara A, Vermund SH, et al. Barriers to antiretroviral therapy adherence in rural Mozambique. BMC Public Health [Internet]. 2011; 11:650. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21846344%5Cnhttp://www.ncbi.nlm.nih.gov/pubmed/21846344.
[4] Jimmy B, Jose Beena Jimmy J, Jose J. Patient Medication Adherence: Measures in Daily Practice. Oman Med Spec Board Oman Med J Oman Med J. 2011; 26 (3):1–3.
[5] Viswanathan S, Detels R, Mehta SH, Macatangay BJC, Kirk GD, Jacobson LP. Level of adherence and HIV RNA suppression in the current era of highly active antiretroviral therapy (HAART). AIDS Behav. 2015; 19 (4):601–11.
[6] UNAIDS. Global AIDS Update 2016. World Heal Organ [Internet]. 2016; (March):422. Available from: http://www.unaids.org/sites/default/files/media_asset/UNAIDS_Gap_report_en.pdf.
[7] Kim S-H, Gerver SM, Fidler S, Ward H. Adherence to antiretroviral therapy in adolescents living with HIV: systematic review and meta-analysis. AIDS [Internet]. 2014; 28 (13):1945–56. Available from: /pmc/articles/PMC4162330/?report=abstract.
[8] Falang KD, Akubaka P, Jimam NS. Patient factors impacting antiretroviral drug adherence in a Nigerian tertiary hospital. J Pharmacol Pharmacother [Internet]. 2012; 3 (2):138–42. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3356954&tool=pmcentrez&rendertype=abstract.
[9] Suleiman IA, Momo A. Adherence to antiretroviral therapy and its determinants among persons living with HIV / AIDS in Bayelsa state, Nigeria. 2016; 14 (1):1–8.
[10] Morojele NK, Kekwaletswe CT, Nkosi S. Associations between alcohol use, other psychosocial factors, structural factors and antiretroviral therapy (ART) adherence among South African ART recipients. AIDS Behav. 2014; 18 (3):519–24.
[11] Alkire S, Chatterjee M, Conconi A, Suman S, Vaz A. Poverty in Rural and Urban Areas Direct comparisons using the global MPI 2014. Oxford Poverty Hum Dev Initiat. 2014; 1–4.
[12] Maskew M, Fox MP, Evans D, Govindasamy D, Jamieson L, Malete G, et al. Insights into Adherence among a Cohort of Adolescents Aged 12-20 Years in South Africa: Reported Barriers to Antiretroviral Treatment. AIDS Res Treat. 2016; 2016.
[13] Hudelson C, Cluver L. Factors associated with adherence to antiretroviral therapy among adolescents living with HIV/AIDS in low- and middle-income countries: a systematic review. AIDS Care [Internet]. 2015; 27 (7):805–16. Available from: http://www.tandfonline.com/doi/full/10.1080/09540121.2015.1011073.
[14] Nabukeera-Barungi N, Elyanu P, Asire B, Katureebe C, Lukabwe I, Namusoke E, et al. Adherence to antiretroviral therapy and retention in care for adolescents living with HIV from 10 districts in Uganda. BMC Infect Dis [Internet]. 2015; 15 (1):520. Available from: http://www.biomedcentral.com/1471-2334/15/520.
[15] Oku AO, Owoaje ET, Ige OK, Oyo-ita A. Prevalence and determinants of adherence to HAART amongst PLHIV in a tertiary health facility in south-south Nigeria. BMC Infect Dis [Internet]. 2013; 13 (1):401. Available from: http://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-2334-13-401.
[16] Chalker JC, Andualem T, Gitau LN, Ntaganira J, Obua C, Tadeg H, et al. Measuring adherence to antiretroviral treatment in resource-poor settings: The feasibility of collecting routine data for key indicators. BMC Health Serv Res [Internet]. 2010; 10 (1):43. Available from: http://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-10-43.
[17] Stirratt MJ, Dunbar-Jacob J, Crane HM, Simoni JM, Czajkowski S, Hilliard ME, et al. Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med. 2015; 5 (4):470–82.
[18] Goon DT, Toriola AL, Shaw BS, Amusa LO, Monyeki MA, Akinyemi O, et al. Anthropometrically determined nutritional status of urban primary schoolchildren in Makurdi, Nigeria. BMC Public Health [Internet]. 2011; 11 (1):769. Available from: http://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-11-769.
[19] Akaakohol MA, Aye GC. Diversification and farm household welfare in Makurdi, Benue State, Nigeria. Dev Stud Res [Internet]. 2014; 1 (1):168–75. Available from: http://www.tandfonline.com/doi/abs/10.1080/21665095.2014.919232.
[20] Lawan UM, Amole G, Gambojahun M, Eneabute J. Psychosocial challenges and adherence to antiretroviral therapy among HIV-positive adolescents attending an ART center in Kano, northwestern Nigeria. 2015; 4 (10):1439–44.
[21] Eng J. Radiology Sample Size Estimation : How Many Individuals Should Be Studied ? 1. 2003; 309–13.
[22] Field A. Discovering Statistics Using IBM SPSS Statistics. London: Sage; 2013.
[23] Anderson DR, Burnham KP, Thompson WL. Null hypothesis testing: Problems, prevalance, and an alternative [Internet]. Vol. 64, Journal of Wildlife Management. 2000. p. 912–23. Available from: http://cat.inist.fr/?aModele=afficheN&cpsidt=792848.
[24] Greenland S, Senn SJ, Rothman KJ, Carlin JB, Poole C, Goodman SN, et al. Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations. Eur J Epidemiol. 2016; 31 (4):337–50.
[25] Arts EJ, Hazuda DJ. HIV-1 antiretroviral drug therapy. Cold Spring Harb Perspect Med. 2012; 2 (4).
[26] Kadhiravan T. Adherence and acquired drug-resistance in tuberculosis: wisdom stood on its head. Indian J Chest Dis Allied Sci [Internet]. 2013; 55 (1):9–10. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23798083.
[27] Masikini P, Mpondo BCT. HIV drug resistance mutations following poor adherence in HIV-infected patient: a case report. Clin case reports [Internet]. 2015; 3 (6):353–6. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4498841&tool=pmcentrez&rendertype=abstract.
[28] Max R. O’Donnell, A. Wolf LWCR, Horsburgh NP. Adherence in the treatment of patients with extensively drug- resistant tuberculosis and HIV in South Africa: A prospective cohort study. J Acquir Immune Defic Syndr. 2014; 67 (1):22–9.
[29] Finocchario-Kessler S, Catley D, Thomson D, Bradley-Ewing A, Berkley-Patton J, Goggin K. Patient communication tools to enhance ART adherence counseling in low and high resource settings. Patient Educ Couns [Internet]. 2012; 89 (1):163–70. Available from: http://dx.doi.org/10.1016/j.pec.2012.03.020.
[30] Pennap G, Abdullahi U, Bako I. Adherence to highly active antiretroviral therapy and its challenges in people living with human immunodeficiency virus (HIV) infection in Keffi, Nigeria. J AIDS HIV Res [Internet]. 2013; 5 (February):52–28. Available from: http://academicjournals.org/journal/JAHR/article-abstract/15301554998.
[31] Aragonés C, Sánchez L, Campos JR, Pérez J. Antiretroviral therapy adherence in persons with HIV/AIDS in Cuba. MEDICC Rev. 2011; 13 (2):17–23.
[32] UNAIDS (Joint United Nations Programme on HIV/AIDS). Ambitious treatment targets: writing the final chapter of the AIDS epidemic: writing the final chapter of the AIDS epidemic. 2014; 1–36.
[33] Inzaule SC, Hamers RL, Kityo C, Rinke De Wit TF, Roura M. Long-term antiretroviral treatment adherence in HIV-infected adolescents and adults in Uganda: A qualitative study. PLoS One [Internet]. 2016; 11 (11):1–15. Available from: http://dx.doi.org/10.1371/journal.pone.0167492.
[34] Akinyemi A, Adedini S, Hounton S, Akinlo A, Adedeji O, Adonri O, et al. Contraceptive use and distribution of high-risk births in Nigeria: A sub-national analysis. Glob Health Action. 2015; 8 (1):1–8.
[35] Bailey H, Thorne C, Malyuta R, Townsend CL, Semenenko I, Cortina-Borja M. Adherence to antiretroviral therapy during pregnancy and the first year postpartum among HIV-positive women in Ukraine. BMC Public Health [Internet]. 2014; 14 (1):993. Available from: http://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-14-993.
[36] Kanters S, Park JJH, Chan K, Ford N, Forrest J, Thorlund K, et al. Review article Use of peers to improve adherence to antiretroviral therapy : a global network meta-analysis. 2016.
[37] Nachega JB, Uthman OA, Anderson J, Ho Y, Stringer JSA, Mcintyre JA. HHS Public Access. 2016; 26 (16):2039–52.
[38] Ekama SO, Herbertson EC, Addeh EJ, Gab-Okafor C V., Onwujekwe DI, Tayo F, et al. Pattern and determinants of antiretroviral drug adherence among Nigerian pregnant women. J Pregnancy. 2012; 2012.
[39] Vitalis D. Factors affecting antiretroviral therapy adherence among HIV-positive pregnant and postpartum women: An adapted systematic review. Int J STD AIDS [Internet]. 2013; 24 (6):427–32. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L370229543%5Cnhttp://dx.doi.org/10.1177/0956462412472807%5Cnhttp://sfx.library.uu.nl/utrecht?sid=EMBASE&issn=09564624&id=doi:10.1177/0956462412472807&atitle=Factors+affecting+antiret.
[40] Kim H, Kim HS, Bowman JD, Cho NH. Comparing diabetic patient characteristics related to stated medication adherence in a rural vs. urban community in Korea. J Clin Pharm Ther. 2016; 41 (1):40–6.
[41] Haberer JE, Kiwanuka J, Nansera D, Ragland K, Mellins C, Bangsberg DR. Multiple measures reveal antiretroviral adherence successes and challenges in HIV-infected Ugandan children. PLoS One. 2012; 7 (5):1–10.
[42] Nyamathi A, Hanson AY, Salem BE, Sinha S, Ganguly KK, Leake B, et al. Impact of a Rural Village Women (Asha) Intervention on Adherence to Antiretroviral Therapy in Southern India. Nurs Res [Internet]. 2012; 61 (5):353–62. Available from: http://search.ebscohost.com/login.aspx?direct=true&db=aph&AN=82086152&site=ehost-live.
[43] Ukwe CV, Ekwunife OI, Udeogaranya OP, Iwuamadi UI. Patients ’ Use of Pill Box. Methods. 2010; 7 (1):10–5.
[44] Akahara C, Nwolisa E, Odinaka K, Okolo S. Assessment of Antiretroviral Treatment Adherence among Children Attending Care at a Tertiary Hospital in Southeastern Nigeria. J Trop Med. 2017; 2017.
[45] Scanlon ML, Vreeman RC. Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings. HIV AIDS (Auckl) [Internet]. 2013; 5:1–17. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3544393&tool=pmcentrez&rendertype=abstract.
[46] Kauf TL, Davis KL, Earnshaw SR, Anne Davis E. Spillover adherence effects of fixed-dose combination HIV therapy. Patient Prefer Adherence. 2012; 6:155–64.
[47] Avong Y, Wyk B, Njab J, Abimiku A, Ndembi N, Okuma J, et al. Adherence to Anti-Retroviral Therapy in North Central Nigeria. Curr HIV Res [Internet]. 2015; 13 (4):268–78. Available from: http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1570-162X&volume=13&issue=4&spage=268.
[48] Kolawole GO, Gilbert HN, Dadem NY, Genberg BL, Agaba PA, Okonkwo P, et al. Patient Experiences of Decentralized HIV Treatment and Care in Plateau State, North Central Nigeria: A Qualitative Study. 2017; 2017.
[49] Ankrah DNA, Koster ES, Mantel-Teeuwisse AK, Arhinful DK, Agyepong IA, Lartey M. Facilitators and barriers to antiretroviral therapy adherence among adolescents in Ghana. Patient Prefer Adherence. 2016; 10:329–37.
Author Information
  • Alberta Health Services, Royal Alexandra Hospital Pharmacy, Edmonton, Canada

  • Department of Public Health, Walden University, Minneapolis, USA

Cite This Article
  • APA Style

    Amom Tor-Anyiin, Frazier Benjamin Beatty. (2018). Difference in Adherence to Anti-Retroviral Therapy in Resource - Constrained Setting: Adolescents and Young Adults in Rural and Urban Residents in Nigeria. Central African Journal of Public Health, 4(6), 168-174. https://doi.org/10.11648/j.cajph.20180406.11

    Copy | Download

    ACS Style

    Amom Tor-Anyiin; Frazier Benjamin Beatty. Difference in Adherence to Anti-Retroviral Therapy in Resource - Constrained Setting: Adolescents and Young Adults in Rural and Urban Residents in Nigeria. Cent. Afr. J. Public Health 2018, 4(6), 168-174. doi: 10.11648/j.cajph.20180406.11

    Copy | Download

    AMA Style

    Amom Tor-Anyiin, Frazier Benjamin Beatty. Difference in Adherence to Anti-Retroviral Therapy in Resource - Constrained Setting: Adolescents and Young Adults in Rural and Urban Residents in Nigeria. Cent Afr J Public Health. 2018;4(6):168-174. doi: 10.11648/j.cajph.20180406.11

    Copy | Download

  • @article{10.11648/j.cajph.20180406.11,
      author = {Amom Tor-Anyiin and Frazier Benjamin Beatty},
      title = {Difference in Adherence to Anti-Retroviral Therapy in Resource - Constrained Setting: Adolescents and Young Adults in Rural and Urban Residents in Nigeria},
      journal = {Central African Journal of Public Health},
      volume = {4},
      number = {6},
      pages = {168-174},
      doi = {10.11648/j.cajph.20180406.11},
      url = {https://doi.org/10.11648/j.cajph.20180406.11},
      eprint = {https://download.sciencepg.com/pdf/10.11648.j.cajph.20180406.11},
      abstract = {Adherence to antiretroviral medicines is essential to halt human immunodeficiency virus progression, increase CD4 counts, decrease virologic impact, and improve quality of life for the infected people. However, sustaining good adherence among adolescents and young adults has been a challenge caused by various problems such as distance to clinic, improved CD4 count which lead to complacency in adherence, and the nature of the environment. Compare to the general population, there is low adherence to anti-retroviral therapy among adolescents and young adults. The study aims to assess the difference in adherence to anti-retroviral therapy between adolescents and young adults in rural and urban areas in resource-constrained settings. This was a retrospective cross-sectional study carried out between January 2011 – December 2014 with a sample size of 287 patients who accessed care for HIV in Federal Medical Center Makurdi, located in the Middle-Belt region of Nigeria. Univariate analysis was conducted using descriptive statistics. Pharmacy refill was used to measure adherence level while the data was analyzed using independent t-test and Chi-Square test. A p value < 0.05 was considered to be statistically significant in the study. In line with literature review, adherence level of at least 95% was considered optimal while anything less than that was deemed suboptimal. Adherence for patients in urban settings was 90.36% (182) while it was 95.12% (105) for those in rural settings (p = 0.001, 95% CI (-8.069, -1.450)). Among patients in rural settings, 57.14% (60) had adherence level of 100% compare to only 42.3% (77) from urban settings (p = 0.080, 95% CI (.052,.116)). Patients in rural settings in Federal Medical Center Makurdi in Benue State are more likely to have a comparative better health output than their counterparts in urban settings going by their adherence levels.},
     year = {2018}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Difference in Adherence to Anti-Retroviral Therapy in Resource - Constrained Setting: Adolescents and Young Adults in Rural and Urban Residents in Nigeria
    AU  - Amom Tor-Anyiin
    AU  - Frazier Benjamin Beatty
    Y1  - 2018/11/13
    PY  - 2018
    N1  - https://doi.org/10.11648/j.cajph.20180406.11
    DO  - 10.11648/j.cajph.20180406.11
    T2  - Central African Journal of Public Health
    JF  - Central African Journal of Public Health
    JO  - Central African Journal of Public Health
    SP  - 168
    EP  - 174
    PB  - Science Publishing Group
    SN  - 2575-5781
    UR  - https://doi.org/10.11648/j.cajph.20180406.11
    AB  - Adherence to antiretroviral medicines is essential to halt human immunodeficiency virus progression, increase CD4 counts, decrease virologic impact, and improve quality of life for the infected people. However, sustaining good adherence among adolescents and young adults has been a challenge caused by various problems such as distance to clinic, improved CD4 count which lead to complacency in adherence, and the nature of the environment. Compare to the general population, there is low adherence to anti-retroviral therapy among adolescents and young adults. The study aims to assess the difference in adherence to anti-retroviral therapy between adolescents and young adults in rural and urban areas in resource-constrained settings. This was a retrospective cross-sectional study carried out between January 2011 – December 2014 with a sample size of 287 patients who accessed care for HIV in Federal Medical Center Makurdi, located in the Middle-Belt region of Nigeria. Univariate analysis was conducted using descriptive statistics. Pharmacy refill was used to measure adherence level while the data was analyzed using independent t-test and Chi-Square test. A p value < 0.05 was considered to be statistically significant in the study. In line with literature review, adherence level of at least 95% was considered optimal while anything less than that was deemed suboptimal. Adherence for patients in urban settings was 90.36% (182) while it was 95.12% (105) for those in rural settings (p = 0.001, 95% CI (-8.069, -1.450)). Among patients in rural settings, 57.14% (60) had adherence level of 100% compare to only 42.3% (77) from urban settings (p = 0.080, 95% CI (.052,.116)). Patients in rural settings in Federal Medical Center Makurdi in Benue State are more likely to have a comparative better health output than their counterparts in urban settings going by their adherence levels.
    VL  - 4
    IS  - 6
    ER  - 

    Copy | Download

  • Sections